E360: The Hardest Lessons I Learned from Building 4 Unicorns
What if the biggest breakthroughs in biotech don’t come from more capital—but from building better systems for innovation? In this episode, I sit down with Errik Anderson, biotech entrepreneur and founder behind multiple billion-dollar companies, to discuss how building infrastructure, not just drugs, is reshaping the…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
E433: AlphaSense’s Chris Ackerson on AI, the Future of Finance & Finding Alpha
E432: $24 Billion Investor on Private Credit, the Psychology of Winning & Fear of Failure
E431: Marty Kausas on AI, Trillion Dollar Startups & Founder Psychology
Similar episodes from other shows
More like How I Invest with David Weisburd →
Y Combinator CEO Garry Tan: Turning Ambitious Misfits into Founders
From Military Discipline to Curing the Impossible
D.A. Wallach Explains Why Biotech VC Is So Different
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.